Interestingly, when we compared IPA for both EZH2-associated genes and PRC2 targets in brain tumors, we found that the first gene set was significantly enriched for Cell-cycle- Cancer-, and Cellular movement-associated genes, compared to PRC2 targets (Figure 2B). This evidence concerns the gene EZH2 and brain neoplasm.